Cardiovascular comorbidity and cardiovascular risk factors in patients with chronic inflammatory skin diseases: A case-control study utilising a population-based administrative database

Italian Journal of Public Health

Volumn 5, Issue 3, 2008, Pages 187-193

  Schmitt, Jochen ^a   Maywald, Ulf ^a   Schmitt, Natalie M ^a   Meurer, Michael ^a   Kirch, Wilhelm ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Atopic dermatitis; Cardiovascular diseases; Case control study; Hypertension; Obesity; Psoriasis

Indexed keywords

EID: 67650160423     PISSN: 17237815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007:370:263-71.
2. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005;352:2314-24.
3. Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, Rolstad T, Margolis DJ. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005;52:23-6.
4. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:121-8.
5. de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2004;9:140-7.
6. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-32.
7. Herd RM, Tidman MJ, Prescott RJ Hunter JA. Prevalence of atopic eczema in the community: the Lothian Atopic Dermatitis study. Br J Dermatol 1996;135:18-9.
8. Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000;25:522-9.
9. Menter A, Griffiths CE. Current and future management of psoriasis. Lancet 2007;370:272-84.
10. Schmitt J, Schakel K, Schmitt N, Meurer M. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol 2007;87:100-11.
11. Hoare C, Li Wan PA, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4:1-191.
12. Finlay AY. Quality of life in atopic dermatitis. J Am Acad Dermatol 2001;45:S64-6.
13. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-4.
14. Schmitt J, Meurer M, Klon M, Frick KD. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema - A population-based study. Br J Dermatol 2007;158:351-9.
15. O'Connell EJ. The burden of atopy and asthma in children. Allergy 2004;59(Suppl 78):7-11.
16. Feldman SR, Fleischer AB, Reboussin DM, Rapp SR, Bradham DD, Exum ML, Clark AR. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997;37:564-9.
17. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004;9:136-9.
18. Bieber T. Atopic dermatitis. N Engl J Med 2008;358:1483-94.
19. Wakkee M, Thion HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007;190:1-9.
20. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-Diaz E, Testa A, Garcia-Porrua C, et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007;57:287-93.
21. Mrowietz U, Elder JT, Barker J. The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res 2006;298:309-19.
22. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004;291:2616-22.
23. Matsubayashi K, Okumiya K, Nakamura T, Fujisawa M, Osaki Y. Global burden of disease. Lancet 1997;350:144.
24. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007;157:68-73.
25. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol 2007;57:347-54.
26. Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: A case-control study. J Am Acad Dermatol 20067;56(4):629-34. Epub 2006 Dec 8.
27. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006;298:321-8.
28. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735-41.
29. Steinhoff M, Steinhoff A, Homey B, Luger TA, Schneider SW. Role of vasculature in atopic dermatitis. J Allergy Clin Immunol 2006;118:190-7.
30. Uehara M, Sugiura H, Tanaka K. Rarity of hypertension in adult patients with atopic dermatitis. Br J Dermatol 2002;146:631-5.
31. Sorensen HT, Sabroe S, Olsen J. A Framework for Evaluation of Secondary Data Sources for Epidemiological Research. International Journal of Epidemiology 1996;25:435-42.
32. von Ferber C. Sekundärdatenforschung - Methodische und theoretische Aspekte. [Secondary data research. Methodological and theoretical Aspects]. In: von Ferber C, Behrens J eds. Public Health mit Gesundheits- und Sozialdaten - Stand und Perspektiven. Sankt Augustin: Asgard-Verlag Hippe, 1997:27-40.
33. Köster I, von Ferber L. Interne Diagnosevalidierung. [Internal diagnosis validation]. In: von Ferber C, Behrens J eds. Public Health mit Gesundheits- und Sozialdaten - Stand und Perspektiven. Sankt Augustin: Asgard-Verlag Hippe, 1997:55-64.
34. Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 20005;52:262-7.
35. Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 2005;210:194-9.
36. Schmitt J, Langan SM, Williams HC. What are the best outcome measurements for atopic eczema? - A systematic review. J Allergy Clin Immunol 2007;120:1389-8.
37. Rosner B, Fundamentals of Biostatistics. Pacific Grove, CA, USA: Duxbury, 2000.
38. Stata Corporation. Stata Statistical Software: Release 8.0, Stata Corporation, College Station, TX. 2002. (Computer Program).
39. Pfaff H, von Pritzbuer E, Kramer M, Driller E. Sozialdatenanalyse als Instrument der Versorgungsforschung. [Social data analysis as instrument for the health care research]. In: Swart I, Ihle P eds. Routinedaten im Gesundheitswesen - Handbuch Sekundärdatenanalyse: Grundlagen, Methoden und Perspektiven. Bern: Verlag Hans Huber, 2005: 331-40.
40. Schmitt J, Maywald U, Schmitt NM, Meurer M, Kirch W. Cardiovascular risk factors and psychiatric comorbidity in patients with atopic eczema. A population-based case-control study. 5th Georg Rajka International Symposium on Atopic Dermatitis Kyoto Abstractbook, 47, 2008.
41. Schmitt NM, Schmitt J. Definition of Public Health. In: Kirch W ed. Encyclopedia of Public Health. Berlin: Springer Verlag, 2008 (in press).
42. Szklo M, Nieto J. Epidemiology Beyond the Basics. Sidbury, Massachusetts: Jones and Barlett Publishers, 2005.
43. Arbeitsgruppe Erhebung und Nutzung von Sekundärdaten (AGENS) der Deutschen Gesellschaft für Sozialmedizin und Prävention (DGSMP). Gute Praxis Sekundärdatenanalyse (GPS). [Good Praxis for the secondary data analysis]. In: Swart E, Ihle P eds. Routinedaten im Gesundheitswesen - Handbuch Sekundärdatenanalyse: Grundlagen, Methoden und Perspektiven. Bern: Verlag Hans Huber, 2005: 405-12.
44. Szklo M. Confounding and interaction. Arch Dermatol 2000;136:1544-6.
45. Naldi L, Chatenoud L, Belloni A, Peserico A, Balato N, Virgili AR, et al. Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology 2008;216:125-30. (2008).
46. Firoozi F, Lemiere C, Beauchesne MF, Forget A, Blais L. Development and validation of database indexes of asthma severity and control. Thorax 2007;62:581-7.